JETEMA Past Earnings Performance
Past criteria checks 2/6
There is insufficient data on JETEMA's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals Industry Growth | 11.3% |
Revenue growth rate | 15.2% |
Return on equity | 26.6% |
Net Margin | 31.7% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
JETEMA (KOSDAQ:216080) Is Posting Healthy Earnings, But It Is Not All Good News
Mar 23Is JETEMA, Co., Ltd.'s (KOSDAQ:216080) Shareholder Ownership Skewed Towards Insiders?
Feb 25JETEMA (KOSDAQ:216080) Is Carrying A Fair Bit Of Debt
Jan 21The JETEMA (KOSDAQ:216080) Share Price Has Gained 110%, So Why Not Pay It Some Attention?
Dec 17Revenue & Expenses Breakdown
How JETEMA makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 63,877 | 20,233 | 15,779 | 11,544 |
31 Mar 24 | 62,551 | 14,196 | 14,811 | 11,026 |
31 Dec 23 | 58,716 | 13,966 | 13,249 | 10,223 |
30 Sep 23 | 57,603 | -21,990 | 13,922 | 8,782 |
30 Jun 23 | 55,439 | -18,144 | 13,707 | 7,449 |
31 Dec 22 | 45,994 | 1,455 | 11,955 | 6,263 |
Quality Earnings: A216080 has high quality earnings.
Growing Profit Margin: A216080 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if A216080's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare A216080's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Earnings vs Industry: A216080 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (21.6%).
Return on Equity
High ROE: Whilst A216080's Return on Equity (26.63%) is high, this metric is skewed due to their high level of debt.